Metraipolis › archive › dc_ebb3d086fcd2

The Interplay Between Immunological and Inflammatory Markers as Key Prognostic Indicators in Elderly Patients with COVID-19 — Europe PMC PMID:41095562

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41095562
DOI
10.3390/healthcare13192477
License (as archived)
solo-consultazione
Archived
2026-11-09T16:53:45.929Z
SHA-256 of the archived text
35b993a9e6b729afcf254fddbe2f928347e548f6d524c9f7d83be2333acd1497
Stable URL of this page
https://metraipolis.com/documento/dc_ebb3d086fcd2

How to cite

The Interplay Between Immunological and Inflammatory Markers as Key Prognostic Indicators in Elderly Patients with COVID-19 — Europe PMC PMID:41095562 — Europe PMC (en), https://europepmc.org/article/MED/41095562 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ebb3d086fcd2 (Metraipolis archive dc_ebb3d086fcd2, sha256 35b993a9e6b729afcf254fddbe2f928347e548f6d524c9f7d83be2333acd1497)
BibTeX
@misc{dcebb3d086fcd2,
  title = {The Interplay Between Immunological and Inflammatory Markers as Key Prognostic Indicators in Elderly Patients with COVID-19 — Europe PMC PMID:41095562},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41095562},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ebb3d086fcd2; sha256 35b993a9e6b729afcf254fddbe2f928347e548f6d524c9f7d83be2333acd1497},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41095562. Agents can read the archived copy with the MCP tool read_document.